The price of gold means squat unless EVG releases assays and gets this stock moving. EAS is almost $4 on similar to EVG assays and the s/p had doubled in the last few months. Although they were wise not to overdilute with cheap financing....Seems like all juniors rise a decent amount on good assay releases yet EVG doesn't. 5-6 weeks between assays is too long. Momentum destroyed. Can't they find a lab that is quicker even if it means paying a little more?...